Mitchel is a reporter for MDedge based in the Philadelphia area. He started with the company in 1992, when it was International Medical News Group (IMNG), and has since covered a range of medical specialties. Mitchel trained as a virologist at Roswell Park Memorial Institute in Buffalo, and then worked briefly as a researcher at Boston Children's Hospital before pivoting to journalism as a AAAS Mass Media Fellow in 1980. His first reporting job was with Science Digest magazine, and from the mid-1980s to early-1990s he was a reporter with Medical World News. @mitchelzoler
News
Higher glycemic time in range may benefit T2D patients
- Author:
- Mitchel L. Zoler, PhD
Publish date: September 28, 2020
News

DAPA-CKD resets eGFR floor for safe SGLT2 inhibitor use
- Author:
- Mitchel L. Zoler, PhD
Publish date: September 25, 2020
News

VERTIS CV: Ertugliflozin’s proven benefits fall short of other SGLT2 inhibitors
- Author:
- Mitchel L. Zoler, PhD
Publish date: September 24, 2020
News

Survival after kidney transplantation lags in diabetes patients
- Author:
- Mitchel L. Zoler, PhD
Publish date: September 23, 2020
News
‘Dose response’ between exercise and improvement in diabetes
- Author:
- Mitchel L. Zoler, PhD
Publish date: September 21, 2020
News
IMPACT-AFib: Single mailing fails to budge oral anticoagulant uptake for AFib
- Author:
- Mitchel L. Zoler, PhD
Publish date: September 2, 2020
News

ESC’s revised NSTE-ACS guidelines embrace hsT, personalized anti-ischemia treatments
- Author:
- Mitchel L. Zoler, PhD
Publish date: August 31, 2020
News

DAPA-CKD: SGLT2 inhibitor benefit extends to chronic kidney disease without diabetes
- Author:
- Mitchel L. Zoler, PhD
Publish date: August 31, 2020
News

EMPEROR-Reduced: Empagliflozin’s HFrEF benefit solidifies class effects
- Author:
- Mitchel L. Zoler, PhD
Publish date: August 30, 2020
News
Weight gain persists as HIV-treatment issue
- Author:
- Mitchel L. Zoler, PhD
Publish date: August 6, 2020
News

SGLT2 inhibitors have a breakout year
- Author:
- Mitchel L. Zoler, PhD
Publish date: August 6, 2020
News

Unexpected rosuvastatin-canagliflozin adverse effect reported
- Author:
- Mitchel L. Zoler, PhD
Publish date: August 4, 2020
News

Cleaner data confirm severe COVID-19 link to diabetes, hypertension
- Author:
- Mitchel L. Zoler, PhD
Publish date: July 27, 2020
News
Terlipressin squeaks by FDA review for hepatorenal syndrome 1
- Author:
- Mitchel L. Zoler, PhD
Publish date: July 17, 2020
News

SGLT2 inhibitors, developed for T2D, now ‘belong to cardiologists and nephrologists’
- Author:
- Mitchel L. Zoler, PhD
Publish date: July 16, 2020